Home
>
National Drug Code (NDC)
>
Cisplatin
Cisplatin - 0703-5747-11 - (Cisplatin)
Drug Information of Cisplatin
| Product NDC: | 0703-5747 |
| Proprietary Name: | Cisplatin |
| Non Proprietary Name: | Cisplatin |
| Active Ingredient(s): | 50 mg/50mL & nbsp; Cisplatin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cisplatin
| Product NDC: | 0703-5747 |
| Labeler Name: | Teva Parenteral Medicines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074656 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000601 |
Package Information of Cisplatin
| Package NDC: | 0703-5747-11 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-5747-11) > 50 mL in 1 VIAL, MULTI-DOSE |
NDC Information of Cisplatin
| NDC Code | 0703-5747-11 |
| Proprietary Name | Cisplatin |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-5747-11) > 50 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 0703-5747 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cisplatin |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20000601 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | CISPLATIN |
| Strength Number | 50 |
| Strength Unit | mg/50mL |
| Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
